AAR named Top Shop for Best Total Solutions Provider Repair by The145.com
WOOD DALE, Ill., April 2, 2025 /PRNewswire/ — AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs,... Read more.
Albemarle Corporation to Release First Quarter 2025 Earnings Results on Wednesday, April 30, 2025
CHARLOTTE, N.C., April 2, 2025 /PRNewswire/ — Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity... Read more.
Caldera Launches PrimeCenter 4.0, Introducing an Easier Way to Automate Digital Printing Job Preparation
DOWNERS GROVE, Ill., April 2, 2025 /PRNewswire/ — Caldera, part of Dover (NYSE: DOV), today announced the release of PrimeCenter 4.0, a major update to its... Read more.
Jake Rakov Announces Run for Congress Against Former Boss Rep. Brad Sherman (CA-32)
Rakov is running on a three-part pledge: term limits, rejecting corporate PAC money, and monthly town halls STUDIO CITY, Calif., April 2, 2025 /PRNewswire/ —... Read more.
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024
TEL AVIV, Israel, April 2, 2025 /PRNewswire/ — Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) (‘Galmed’ or the ‘Company’), a clinical-stage... Read more.
Lucid Group, Inc. Announces Proposed Convertible Senior Notes Offering
NEWARK, Calif., April 2, 2025 /PRNewswire/ — Lucid Group, Inc. (Nasdaq: LCID) today announced its intention to offer, subject to market and other conditions,... Read more.
Lam Research Corporation Announces March Quarter Financial Conference Call
FREMONT, Calif., April 2, 2025 /PRNewswire/ — Lam Research Corp. (NASDAQ: LRCX) today announced that the company will host its quarterly financial conference... Read more.
Curis to Present at Upcoming Healthcare Conference in April
LEXINGTON, Mass., April 2, 2025 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an... Read more.
Plexium Announces Two Oral Presentations and Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
SAN DIEGO, April 2, 2025 /PRNewswire/ — Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation company, today announced that initial... Read more.
Enliven Therapeutics Announces Poster Presentations at the 2025 AACR Annual Meeting
BOULDER, Colo., April 2, 2025 /PRNewswire/ — Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company... Read more.